During COMy 2020, Mohamad Mohty, Saint-Antoine Hospital and Sorbonne University, Paris, FR, discussed highlights from the first virtual COMy meeting.
FDA clears FT538, the first CRISPR-edited, iPSC-derived cell therapy, for investigation as a new drug in AML and MM
On May 20, 2020, the U.S. Food & Drug Administration (FDA) cleared FT538, the first CRISPR-edited, induced pluripotent stem cell...
COMy 2020 | Highlights from the oral abstract session
A summary of the session entitled ‘Oral Abstracts’, which took place during the 6th World Congresses on Controversies in Multiple Myeloma (COMy) meeting, held virtually on Friday 15 May, 2020.
What are the key diagnostic criteria for confirming MGUS?
During COMy 2020, Graham Jackson, Northern Institute for Cancer Research, UK, spoke to the Multiple Myeloma Hub. We asked: What are the key diagnostic criteria for confirming MGUS?
" The MM Hub is the ideal platform for the latest news about myeloma. You will find information about the most recent data, and also personal experiences from experts managing myeloma patients in their clinical practice. "